By David Tuller, DrPH This is a crowdfunding month for UC Berkekely and Trial By Error. If you’d like to support my work, here’s the link: https://crowdfund.berkeley.edu/project/47768(Donations are tax-deductible for US taxpayers.) ********** The UK Medical Research Council recently awarded £800,000 over four years to PRIME, a partnership between Action For ME and the University …
By David Tuller, DrPH Last year, a team from the University of Edinburgh released a pre-print called “Replicated blood-based biomarkers for myalgic encephalomyelitis not explicable by inactivity.” At the time, I posted an interview with the lead investigator, Chris Ponting, a professor of genetics at the university. The peer-reviewed version of the study has just …
Trial By Error: Edinburgh Study Links ME/CFS to “Blood-Based Biomarkers” Read More »
I joined Marc Pelletier on episode 60 of Futures in Biotech for a conversation with Malcolm Whiteway about one of the most powerful genetic model systems: Saccharomyces cerevisiae. [audio:http://www.podtrac.com/pts/redirect.mp3/twit.cachefly.net/fib0069.mp3 | titles=FiB 69] Download FiB #69 (46 MB .mp3, 95 minutes) Download video (231 MB .mp4)
I joined Marc Pelletier on episode 56 of Futures in Biotech for a conversation with Stanford University School of Medicine Professor Karla Kirkegaard. We talked about RNA viruses – where they came from, where they are going, and Dr. Kirkegaard’s unique approach to discovering antiviral drugs. Don’t miss this episode: Dr. Kirkegaard is a brilliant and …
Download: .wmv (333 MB) | .mp4 (75 MB) Visit the virology W3310 home page for a complete list of course resources.
